SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Cost-effectiveness of Screening for Type 2 Diabetes
2 references·7 citing·30 second hop
The Cost-effectiveness of Screening for Type 2 Diabetes (1998)The Cost-effectiveness of Screening for T…Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia (1997)Model of Complications of NID…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008? (2020)Cost-effectiveness of Interve…Outcome Measurement in Economic Evaluations of Public Health Interventions: a Role for the Capability Approach? (2010)Outcome Measurement in Econom…Diabetes Epidemiology: Guiding Clinical and Public Health Practice (2007)Diabetes Epidemiology: Guidin…What determines the cost-effectiveness of diabetes screening? (2006)What determines the cost-effe…Cost Effectiveness of Preventive Interventions in Type 2 Diabetes Mellitus (2006)Cost Effectiveness of Prevent…Discounting Health Effects in Pharmacoeconomic Evaluations (2005)Discounting Health Effects in…Application of Economic Analysis to Diabetes and Diabetes Care (2004)Application of Economic Analy…Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control and Complications Trial (1996)Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes (2002)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The MOS 36-ltem Short-Form Health Survey (SF-36) (1992)An investigation of the construct validity of the ICECAP-A capability measure (2012)VALUING THE ECONOMIC BENEFITS OF COMPLEX INTERVENTIONS: WHEN MAXIMISING HEALTH IS NOT SUFFICIENT (2012)Applications of the Capability Approach in the Health Field: A Literature Review (2016)A Treatise of Human Nature (1739)11. Reasons and Persons (1986)Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma (2009)Use of Global Visual Acuity Data in a Time Trade-off Approach to Calculate the Cost Utility of Cataract Surgery (2009)Discounting in the evaluation of the cost-effectiveness of a vaccination programme: A critical review (2015)Economic Costs of Diabetes in the U.S. in 2002 (2003)A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment (2010)Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study (2012)Valuing Health-Related Quality of Life in Diabetes (2002)Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program (2003)The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance (2005)Handling Uncertainty in Cost-Effectiveness Models (2000)Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis (2004)Economic Costs of Diabetes in the U.S. in 2017 (2018)Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data (2023)Cost-effectiveness of the 3E model in diabetes management: a machine learning approach to assess long-term economic impact (2025)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 (1998)Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) (2000)Systematic review of the use and value of computer simulation modelling in population health and health care delivery (2003)
this work references cited by second hop

References

  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 1997Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia333 cited

Cited by

  • 2020Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?164 cited
  • 2010Outcome Measurement in Economic Evaluations of Public Health Interventions: a Role for the Capability Approach?135 cited
  • 2004Application of Economic Analysis to Diabetes and Diabetes Care94 cited
  • 2005Discounting Health Effects in Pharmacoeconomic Evaluations66 cited
  • 2007Diabetes Epidemiology: Guiding Clinical and Public Health Practice56 cited
  • 2006What determines the cost-effectiveness of diabetes screening?54 cited
  • 2006Cost Effectiveness of Preventive Interventions in Type 2 Diabetes Mellitus48 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work